Tenax Therapeutics (NASDAQ:TENX) Earns Outperform Rating from Analysts at William Blair
William Blair assumed coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Free Report) in a report released on Monday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating on the specialty pharmaceutical company’s stock. William Blair also issued estimates for Tenax Therapeutics’ Q3 2024 earnings at ($1.50) EPS, Q4 2024 earnings at ($1.35) EPS, […]
More Stories
Citigroup Increases Medtronic (NYSE:MDT) Price Target to $92.00
Medtronic (NYSE:MDT – Free Report) had its target price increased by Citigroup from $85.00 to $92.00 in a research note...
Integer (NYSE:ITGR) Price Target Raised to $145.00
Integer (NYSE:ITGR – Free Report) had its price objective lifted by Bank of America from $135.00 to $145.00 in a...
UN condemns deadly West Bank airstrike, attacks on Gaza schools
The UN chief has strongly condemned the killing of several Palestinians, including women and children, who died when a residential...
Lamb Weston (NYSE:LW) Releases FY 2025 Earnings Guidance
Lamb Weston (NYSE:LW – Get Free Report) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per...
Dbs Bank Upgrades Volkswagen (OTCMKTS:VWAGY) to “Hold”
Volkswagen (OTCMKTS:VWAGY – Get Free Report) was upgraded by Dbs Bank to a “hold” rating in a research note issued...
News from the WHO: WHO adds an HPV vaccine for single-dose use https://ift.tt/wCOnRQP October 04, 2024 at 07:00AM
Published on October 04, 2024 at 07:00AM View on website